I‐Tsang Chiang

1.1k total citations
44 papers, 891 citations indexed

About

I‐Tsang Chiang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, I‐Tsang Chiang has authored 44 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in I‐Tsang Chiang's work include NF-κB Signaling Pathways (7 papers), Cancer, Stress, Anesthesia, and Immune Response (6 papers) and Genomics, phytochemicals, and oxidative stress (4 papers). I‐Tsang Chiang is often cited by papers focused on NF-κB Signaling Pathways (7 papers), Cancer, Stress, Anesthesia, and Immune Response (6 papers) and Genomics, phytochemicals, and oxidative stress (4 papers). I‐Tsang Chiang collaborates with scholars based in Taiwan, United States and South Korea. I‐Tsang Chiang's co-authors include Fei‐Ting Hsu, Yu‐Chang Liu, Jeng‐Jong Hwang, Jing‐Gung Chung, Wuu‐Jyh Lin, Hsin‐Ell Wang, Wei‐Ting Chen, Weishu Wang, Hsi‐Feng Tu and Elena Perevedentseva and has published in prestigious journals such as ACS Nano, PLoS ONE and Cancer Research.

In The Last Decade

I‐Tsang Chiang

42 papers receiving 880 citations

Peers

I‐Tsang Chiang
Sreenivas Nannapaneni United States
Wei Han China
Qiaoyun Chen China
Emilly S. Villodre United States
Aurélie Perraud France
Nasser Samadi Iran
Jianqiang Chen China
Jihong Zhang China
Sreenivas Nannapaneni United States
I‐Tsang Chiang
Citations per year, relative to I‐Tsang Chiang I‐Tsang Chiang (= 1×) peers Sreenivas Nannapaneni

Countries citing papers authored by I‐Tsang Chiang

Since Specialization
Citations

This map shows the geographic impact of I‐Tsang Chiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Tsang Chiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Tsang Chiang more than expected).

Fields of papers citing papers by I‐Tsang Chiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I‐Tsang Chiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Tsang Chiang. The network helps show where I‐Tsang Chiang may publish in the future.

Co-authorship network of co-authors of I‐Tsang Chiang

This figure shows the co-authorship network connecting the top 25 collaborators of I‐Tsang Chiang. A scholar is included among the top collaborators of I‐Tsang Chiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I‐Tsang Chiang. I‐Tsang Chiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Jheng‐Yan, et al.. (2025). Impact of sodium-glucose cotransporter-2 inhibitors on ovarian cancer risk in patients with type 2 diabetes mellitus: A multi-institutional TriNetX study. Diabetes Research and Clinical Practice. 222. 112109–112109. 3 indexed citations
3.
Hsu, Fei‐Ting, Yu‐Cheng Chin, Li‐Xing Yang, et al.. (2024). Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against Glioblastoma and Pancreatic Cancer. ACS Nano. 18(42). 28764–28781. 15 indexed citations
4.
5.
Liu, Yu‐Chang, et al.. (2023). Clinical Effect of Moisturized Skin Care on Radiation Dermatitis of Head and Neck Cancer. In Vivo. 37(6). 2776–2785. 3 indexed citations
6.
Chiang, I‐Tsang, Bashir Lawal, Yueh‐Shan Weng, et al.. (2023). A Novel Isotope-labeled Small Molecule Probe CC12 for Anti-glioma via Suppressing LYN-mediated Progression and Activating Apoptosis Pathways. International Journal of Biological Sciences. 19(10). 3209–3225. 4 indexed citations
7.
Chiang, I‐Tsang, Yu‐Chang Liu, Huashan Liu, et al.. (2022). Regorafenib Reverses Temozolomide-Induced CXCL12/CXCR4 Signaling and Triggers Apoptosis Mechanism in Glioblastoma. Neurotherapeutics. 19(2). 616–634. 19 indexed citations
8.
Weng, Yueh‐Shan, et al.. (2022). Lenvatinib Synergistically Promotes Radiation Therapy in Hepatocellular Carcinoma by Inhibiting Src/STAT3/NF-κB-Mediated Epithelial–Mesenchymal Transition and Metastasis. International Journal of Radiation Oncology*Biology*Physics. 115(3). 719–732. 19 indexed citations
9.
Hsu, Fei‐Ting, et al.. (2022). Synergistic effect of Abraxane that combines human IL15 fused with an albumin‐binding domain on murine models of pancreatic ductal adenocarcinoma. Journal of Cellular and Molecular Medicine. 26(7). 1955–1968. 9 indexed citations
10.
Chiang, I‐Tsang, et al.. (2022). Regorafenib enhances antitumor immune efficacy of anti-PD-L1 immunotherapy on oral squamous cell carcinoma. Biomedicine & Pharmacotherapy. 147. 112661–112661. 18 indexed citations
11.
Chen, Wei‐Ting, et al.. (2021). Amentoflavone Induces Cell-cycle Arrest, Apoptosis, and Invasion Inhibition in Non-small Cell Lung Cancer Cells. Anticancer Research. 41(3). 1357–1364. 21 indexed citations
12.
Lee, Yuan‐Hao, I‐Tsang Chiang, Wei‐Ting Chen, et al.. (2021). Suppression of EGFR/PKC-δ/NF-κB Signaling Associated With Imipramine-Inhibited Progression of Non-Small Cell Lung Cancer. Frontiers in Oncology. 11. 735183–735183. 22 indexed citations
13.
Hsu, Fei‐Ting, et al.. (2020). Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF‐κB signalling participate in anti‐glioblastoma of imipramine. Journal of Cellular and Molecular Medicine. 24(7). 3982–4000. 32 indexed citations
14.
Tu, Hsi‐Feng, et al.. (2020). Beneficial effect of fluoxetine on anti-tumor progression on hepatocellular carcinoma and non-small cell lung cancer bearing animal model. Biomedicine & Pharmacotherapy. 126. 110054–110054. 36 indexed citations
15.
Liu, Yu‐Chang, et al.. (2020). Therapeutic Efficacy and Inhibitory Mechanism of Regorafenib Combined With Radiation in Colorectal Cancer. In Vivo. 34(6). 3217–3224. 9 indexed citations
16.
Chen, Jiann‐Hwa, I‐Tsang Chiang, & Fei‐Ting Hsu. (2019). Protein Kinase B Inactivation Is Associated with Magnolol-Enhanced Therapeutic Efficacy of Sorafenib in Hepatocellular Carcinoma In Vitro and In Vivo. Cancers. 12(1). 87–87. 16 indexed citations
17.
Chung, Jing‐Gung, et al.. (2019). Amentoflavone Induces Apoptosis and Reduces Expression of Anti-apoptotic and Metastasis-associated Proteins in Bladder Cancer. Anticancer Research. 39(7). 3641–3649. 33 indexed citations
18.
Chiang, I‐Tsang, Wei‐Ting Chen, Chih‐Wei Tseng, et al.. (2017). Hyperforin Inhibits Cell Growth by Inducing Intrinsic and Extrinsic Apoptotic Pathways in Hepatocellular Carcinoma Cells. Anticancer Research. 37(1). 161–168. 45 indexed citations
19.
Liu, Jen‐Wei, Chih-Hao Wu, I‐Tsang Chiang, et al.. (2017). n-Butylidenephthalide exhibits protection against neurotoxicity through regulation of tryptophan 2, 3 dioxygenase in spinocerebellar ataxia type 3. Neuropharmacology. 117. 434–446. 25 indexed citations
20.
Fang, Chun‐Kai, Hongwen Chen, I‐Tsang Chiang, et al.. (2012). Mirtazapine Inhibits Tumor Growth via Immune Response and Serotonergic System. PLoS ONE. 7(7). e38886–e38886. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sreenivas Nannapaneni Breakdown of academic impact, for papers by Wei Han Breakdown of academic impact, for papers by Qiaoyun Chen Breakdown of academic impact, for papers by Emilly S. Villodre Breakdown of academic impact, for papers by Aurélie Perraud Breakdown of academic impact, for papers by Nasser Samadi Breakdown of academic impact, for papers by Jianqiang Chen Breakdown of academic impact, for papers by Jihong Zhang
Rankless by CCL
2026